Patent ID: 11955232
Assignee: DEEPWELL DTX
Field: Medical technology (Instruments)
Classification: CPC G | IPC G

Claim 0:
1. An immersive medicine generation system comprising:
a communication module;
a deployment layer operably coupled to an uncontrolled digital asset deployment environment (DADE) operably coupled to at least one user device through the communication module, the deployment layer comprising a plurality of therapeutic digital assets (TDAs);
a data store operably coupled to the communication module, comprising a program of instructions and a therapeutic modality comprising at least one therapeutic induction mechanism;
a therapeutic digital asset management engine (TDAME) configured to cause quality management operations to be performed; and,
a processor operably coupled to the data store and the TDAME such that, when the processor executes the program of instructions, the processor causes operations to be performed to cause the quality management operations to be performed while generating immersive medicine using a non-medical digital asset (NMDA) comprising a videogame, the operations comprising:
receive the NMDA at the communication module, wherein the NMDA is submitted from a game developer using the at least one user device to be considered as a medical digital asset;
generate a first metadata structure (MDS) based on an evaluation between the NMDA and the therapeutic modality;
generate a TDA based on the first MDS, wherein the first MDS comprising an association between the TDA and the therapeutic modality;
receive a risk analysis signal corresponding to the therapeutic modality;
generate, in response to the risk analysis signal, a second MDS comprising a risk mitigation associated with the TDA;
generate, based on the second MDS, a third MDS, wherein the third MDS comprises a test profile comprising a test input, a test operation to be applied to the TDA based on the test input and an approved test result corresponding to the test operation;
upon receiving a result signal corresponding to an acceptable test result generated in response to application of the test operation to the TDA, generate, in response to the result signal, a fourth MDS associating the acceptable test result with the TDA;
generate, based on the fourth MDS, an incorporation signal to induce incorporation of the TDA with the first MDS to the deployment layer, such that the plurality of TDAs generated from NMDAs and incorporated in the deployment layer are verified based on the test profile;
transmit an activation signal such that the plurality of TDAs are operated into an accessible state in the uncontrolled DADE such that at least one implementation device communicably coupled to the uncontrolled DADE is provided access to the plurality of TDAs;
upon receiving a first signal corresponding to a change in a non-medical digital content of the TDA;
retrieve, from a first data store and in response to the first signal, the third MDS corresponding to the TDA;
apply the test profile to the TDA based on the change in the non-medical digital content to generate a test result corresponding to an outcome of application of the test operation to the TDA after the change; and,
automatically generate, in response to determining that the generated test result does not correspond to the approved test result, a second signal configured to automatically induce deactivation of the TDA in the deployment layer such that the TDA is suspended from the accessible state in the uncontrolled DADE.